1. Home
  2. JYNT vs VIGL Comparison

JYNT vs VIGL Comparison

Compare JYNT & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JYNT
  • VIGL
  • Stock Information
  • Founded
  • JYNT 2010
  • VIGL 2020
  • Country
  • JYNT United States
  • VIGL United States
  • Employees
  • JYNT N/A
  • VIGL N/A
  • Industry
  • JYNT Multi-Sector Companies
  • VIGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • JYNT Miscellaneous
  • VIGL Health Care
  • Exchange
  • JYNT Nasdaq
  • VIGL Nasdaq
  • Market Cap
  • JYNT 170.1M
  • VIGL 134.9M
  • IPO Year
  • JYNT 2014
  • VIGL 2022
  • Fundamental
  • Price
  • JYNT $11.52
  • VIGL $8.07
  • Analyst Decision
  • JYNT Strong Buy
  • VIGL Buy
  • Analyst Count
  • JYNT 2
  • VIGL 7
  • Target Price
  • JYNT $15.50
  • VIGL $8.00
  • AVG Volume (30 Days)
  • JYNT 73.1K
  • VIGL 940.6K
  • Earning Date
  • JYNT 08-07-2025
  • VIGL 08-12-2025
  • Dividend Yield
  • JYNT N/A
  • VIGL N/A
  • EPS Growth
  • JYNT N/A
  • VIGL N/A
  • EPS
  • JYNT N/A
  • VIGL N/A
  • Revenue
  • JYNT $52,789,479.00
  • VIGL N/A
  • Revenue This Year
  • JYNT $9.48
  • VIGL N/A
  • Revenue Next Year
  • JYNT $11.15
  • VIGL N/A
  • P/E Ratio
  • JYNT N/A
  • VIGL N/A
  • Revenue Growth
  • JYNT 71.05
  • VIGL N/A
  • 52 Week Low
  • JYNT $9.58
  • VIGL $1.31
  • 52 Week High
  • JYNT $15.32
  • VIGL $8.07
  • Technical
  • Relative Strength Index (RSI)
  • JYNT 54.97
  • VIGL 89.07
  • Support Level
  • JYNT $11.71
  • VIGL $7.86
  • Resistance Level
  • JYNT $12.27
  • VIGL $8.05
  • Average True Range (ATR)
  • JYNT 0.62
  • VIGL 0.03
  • MACD
  • JYNT -0.01
  • VIGL -0.13
  • Stochastic Oscillator
  • JYNT 46.05
  • VIGL 100.00

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.

About VIGL Vigil Neuroscience Inc.

Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.

Share on Social Networks: